- January 21, 2022
June 12, 2021
NALIRIFOX Shows Promise in Early Studies BookmarkLola Rahib, PhD
Article from Let’s Win! Pancreatic Cancer: NALIRIFOX, a combination of liposomal irinotecan (Onivyde) with fluorouracil (5-FU), leucovorin, and oxaliplatin is shown to be safe as a first line treatment in locally advanced or metastatic pancreatic cancer.